Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 186.02 million compared to CNY 173.22 million a year ago. Revenue was CNY 192.5 million compared to CNY 173.32 million a year ago. Net loss was CNY 26.22 million compared to CNY 17.1 million a year ago. Basic loss per share from continuing operations was CNY 0.1649 compared to CNY 0.1221 a year ago. Diluted loss per share from continuing operations was CNY 0.1649 compared to CNY 0.1221 a year ago.